Scientists Identify the Immune Cells Behind Beta Cell Destruction in Type 1 Diabetes

Type 1 diabetes develops when the immune system attacks insulin-producing beta cells in the pancreas. Scientists have long known this happens, but pinpointing exactly which immune cells are responsible and what makes them different from other cells has been challenging. A new study published in bioRxiv offers an important clue: the key distinguishing feature is whether a CD8 T cell (a type of white blood cell) can directly react to and attack beta cells.

Researchers examined CD8 T cells from pancreas samples taken from organ donors—some with Type 1 diabetes and some without. They then tested whether these cells could recognize and respond to beta-like cells grown in the laboratory from stem cells.

The findings showed a striking pattern. CD8 T cells that strongly reacted to beta cells were found almost exclusively in the pancreases of donors with Type 1 diabetes. In contrast, these highly reactive cells were largely absent from donors without the disease. This suggests that beta cell reactivity is a reliable marker of disease-associated immune cells.

Importantly, not all T cells in the pancreas are destructive. The researchers also found virus-fighting CD8 T cells living in both healthy and diabetic pancreases. These virus-specific cells did not attack the beta-like cells in the lab, indicating that living in the pancreas alone doesn't make a T cell harmful. The deciding factor appears to be whether the cell can recognize and react to beta cells themselves.

Among the beta cell-reactive T cells found in people with Type 1 diabetes, the vast majority responded to insulin (specifically preproinsulin, the precursor to insulin). In contrast, T cells that reacted to other major islet proteins were rarely found. This narrow focus suggests that even within the beta cell attack, the immune system in Type 1 diabetes homes in on one particular target.

This finding challenges an earlier assumption: despite beta cell specificity being a hallmark of Type 1 diabetes, T cells reactive to other native islet proteins apparently don't infiltrate the islets in meaningful numbers. The disease appears to center on insulin as the dominant antigen.

By identifying beta cell reactivity as the defining functional feature of disease-causing T cells, researchers now have a clearer framework for understanding why beta cells are selectively destroyed. This understanding could guide the development of new tools to monitor disease progression and identify which immune cells are truly driving the attack.

The findings also create a foundation for therapeutic strategies aimed specifically at the T cells that matter most in Type 1 diabetes. Instead of broadly targeting all immune activity in the pancreas, future treatments might focus on neutralizing or redirecting only the CD8 T cells that react to beta cells—potentially offering more precise interventions.

Source: bioRxiv : the preprint server for biology. Evidence type: PubMed indexed literature. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.